Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer

NCT00005871 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: fluorouracil
DRUG: rubitecan

Sponsor

Astex Pharmaceuticals, Inc.